Skip to Main Navigation

Development Objective

The project development objective (PDO) is to prevent, detect and respond to the threat posed by COVID-19 in Zambia and strengthen national public health systems for preparedness.

Key Details

Project Details

  • P174185

  • Closed

  • John Makumba , Fernando Montenegro Torres

  • Republic of Zambia

  • Zambia

  • October 20, 2020

  • (as of board presentation)

    October 20, 2020

  • January 12, 2021

  • US$ 25.00 million

  • Ministry of Health,Zambia National Public Health Institute

  • Eastern and Southern Africa

  • 2021

  • US$ 25.00 million

  • N/A

  • February 12, 2024

  • December 31, 2024

  • Yes

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 20.00
Global Financing Facility 5.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 20.00
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount 5.00
Total Project Cost** 25.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Oct 20, 2020 IDA-67750 Loan Commitment 20,000,000.00
Jun 28, 2021 IDA-69680 Loan Commitment 14,000,000.00
Dec 7, 2023 IDA-67750 Loan Disb 270,431.25
Dec 7, 2023 IDA-67750 Loan Disb 88,754.72
Nov 22, 2023 IDA-67750 Int Charges 746.21
Nov 22, 2023 IDA-67750 Int Charges 37,286.14
Nov 22, 2023 IDA-67750 Int Charges 37,286.14
Nov 22, 2023 IDA-67750 Int Charges 61,025.36
Oct 18, 2023 IDA-67750 Loan Disb 102,020.00
Jul 23, 2024 IDA-67750 Loan Disb 92,708.38
May 8, 2024 IDA-67750 Loan Disb 249,408.12
Apr 5, 2024 IDA-67750 Loan Disb 21,652.84
Apr 15, 2024 IDA-67750 Loan Disb 40,881.53
Apr 12, 2024 IDA-67750 Loan Disb 217,480.64
Nov 21, 2023 IDA-67750 Loan Disb 54,413.86
Apr 24, 2024 IDA-67750 Loan Disb 47,504.56
Mar 15, 2024 IDA-69680 Int Charges 1,818.74
Mar 7, 2024 IDA-67750 Loan Disb 92,576.82
Mar 18, 2024 IDA-69680 Int Charges 55,795.52
Mar 18, 2024 IDA-69680 Int Charges 31,658.56
Mar 18, 2024 IDA-69680 Int Charges 31,658.56
Mar 15, 2024 IDA-69680 Int Charges 1,818.74
Feb 9, 2024 IDA-67750 Loan Disb 41,338.62
Feb 21, 2024 IDA-67750 Loan Disb 40,942.80
Aug 16, 2024 IDA-67750 Loan Disb 7,103.84
May 16, 2024 IDA-67750 Loan Disb 29,640.00
Jun 27, 2024 IDA-67750 Loan Disb 39,495.17
Jun 27, 2024 IDA-67750 Loan Disb 604,728.50
Sep 6, 2023 IDA-67750 Loan Disb 204,040.00
Sep 7, 2023 IDA-67750 Loan Disb 3,000.00
May 30, 2023 IDA-67750 Loan Disb 405,700.56
Sep 19, 2023 IDA-69680 Int Charges 26,548.96
Sep 19, 2023 IDA-69680 Int Charges 26,548.96
Aug 29, 2023 IDA-67750 Loan Disb 337,475.25
Sep 19, 2023 IDA-69680 Int Charges 44,248.24
Nov 15, 2023 IDA-67750 Loan Disb 66,540.18
Jan 4, 2024 IDA-67750 Loan Disb 588,191.30
Jan 4, 2024 IDA-67750 Loan Disb 161,699.60
Oct 25, 2023 IDA-67750 Loan Disb 41,146.62
Jan 3, 2024 IDA-67750 Loan Disb 163,783.22
Nov 24, 2021 IDA-67750 Int Charges 6,596.09
Nov 24, 2021 IDA-67750 Int Charges 6,596.09
Nov 24, 2021 IDA-67750 Int Charges 10,993.52
Jun 30, 2021 IDA-67750 Loan Disb 2,400,000.00
Mar 14, 2022 IDA-67750 Loan Disb 854,261.75
May 15, 2022 IDA-67750 Int Charges 405.07
May 15, 2022 IDA-67750 Int Charges 405.07
Jun 9, 2022 IDA-67750 Int Charges 16,367.21
Jun 9, 2022 IDA-67750 Int Charges 9,529.26
Jun 9, 2022 IDA-67750 Int Charges 9,529.26
May 2, 2022 IDA-67750 Loan Disb 1,146,444.20
Jun 23, 2022 IDA-67750 Loan Disb 1,270,850.50
Mar 7, 2022 IDA-67750 Loan Disb 51,990.74
Nov 7, 2022 IDA-67750 Loan Disb 119,809.51
Nov 7, 2022 IDA-67750 Loan Disb 57,937.66
Nov 18, 2022 IDA-67750 Loan Disb 190,535.94
Jun 27, 2024 IDA-67750 Loan Disb 4,956.54
Jun 28, 2024 IDA-67750 Loan Disb 36,674.10
Jun 24, 2024 IDA-67750 Loan Disb 43,231.35
Jun 27, 2024 IDA-67750 Loan Disb 40,572.42
Jun 27, 2024 IDA-67750 Loan Disb 63,948.29
Jun 27, 2024 IDA-67750 Loan Disb 364,214.30
May 21, 2024 IDA-67750 Loan Disb 194,828.12
Jun 27, 2024 IDA-67750 Loan Disb 786,271.20
May 13, 2024 IDA-67750 Loan Disb 41,486.78
May 15, 2024 IDA-67750 Int Charges 1,111.80
May 15, 2024 IDA-67750 Int Charges 45,222.58
May 15, 2024 IDA-67750 Int Charges 45,222.58
May 15, 2024 IDA-67750 Int Charges 75,370.92
Aug 1, 2024 IDA-67750 Loan Disb 112,404.80
Jun 6, 2024 IDA-67750 Loan Disb 311,724.97
Apr 23, 2024 IDA-67750 Loan Disb 58,603.77
Jun 6, 2024 IDA-67750 Loan Disb 50,451.30
Jul 1, 2024 IDA-67750 Loan Disb -63,884.30
Dec 23, 2022 IDA-67750 Loan Disb 179,714.27
Dec 23, 2022 IDA-67750 Loan Disb 90,876.62
May 16, 2023 IDA-67750 Int Charges 29,533.11
May 16, 2023 IDA-67750 Int Charges 29,533.11
Apr 21, 2023 IDA-69680 Loan Disb 9,037,630.00
Feb 16, 2023 IDA-67750 Loan Disb 320,300.56
Dec 20, 2022 IDA-67750 Loan Disb 867,335.25
Dec 16, 2022 IDA-67750 Loan Disb 277,619.97
Nov 25, 2022 IDA-67750 Int Charges 192.48
Nov 25, 2022 IDA-67750 Int Charges 19,534.58
Nov 25, 2022 IDA-67750 Int Charges 19,534.58
Nov 25, 2022 IDA-67750 Int Charges 31,536.79
Nov 3, 2022 IDA-67750 Loan Disb 400,331.62
Nov 7, 2022 IDA-67750 Loan Disb 185,079.98
Aug 3, 2023 IDA-67750 Loan Disb 65,209.62
Sep 8, 2023 IDA-67750 Loan Disb 310,875.56
Aug 1, 2023 IDA-67750 Loan Disb 205,362.44
May 16, 2023 IDA-67750 Int Charges 1,047.79
May 16, 2023 IDA-67750 Int Charges 48,468.63
May 18, 2023 IDA-67750 Loan Disb 519,361.70
Jun 30, 2023 IDA-67750 Loan Disb 378,544.22
Sep 6, 2023 IDA-67750 Loan Disb 62,209.63

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Moderately Satisfactory 2024-08-25
Financial Management Moderately Satisfactory 2024-08-25
Monitoring and Evaluation Moderately Satisfactory 2024-08-25
Overall Implementation Progress (IP) Moderately Satisfactory 2024-08-25
Procurement Moderately Satisfactory 2024-08-25
Project Management Moderately Satisfactory 2024-08-25

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with SARS-CoV-2 diagnostic capacity (Number)Value3.0017.0025.00
    DateDecember 30, 2019June 2, 2023June 30, 2024
    Comment
  • Number of designated health facilities with COVID-19 case management capacityValue3.0050.0025.00
    DateDecember 31, 2019June 2, 2023June 30, 2024
    Comment
  • Proportion of eligible population fully vaccinated, which is included in the priority targets defined in the National Plan (by gender)Value0.0085.5090.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Quarterly number of first Outpatient Department (OPD) consultations [by Gender] (Number)Value5525000.002298523.002400000.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with capacity for genomic sequencingValue0.005.003.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Monthly average number of infants receiving 3 doses of Pentavalent vaccineValue50000.0053530.0055000.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Key messages and materials developed for public communications and advocacy, in alignment with demand plan, and establishing two-way feedback and response mechanismsValueNOYESYES
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Number of health workers trained trained in IPC interventionsValue5500.005600.005700.00
    DateDecember 30, 2022June 2, 2023June 30, 2024
    Comment
  • Number of fully equipped provincial blood storage hubs established and operational in compliance with national standardsValue0.000.006.00
    DateNovember 30, 2023November 30, 2023June 30, 2024
    Comment
  • Percentage of designated hospitals with functional oxygen delivery equipmentValue0.0037.0060.00
    DateDecember 30, 2019June 2, 2023June 30, 2024
    Comment
  • Number of operational research studies conducted to inform the national COVID-19 responseValue0.000.003.00
    DateDecember 30, 2020June 2, 2023June 30, 2024
    Comment
  • Number of dedicated quarantine and isolation centersValue3.0048.0080.00
    DateDecember 30, 2019June 2, 2023June 30, 2024
    Comment
  • Number of health workers trained in COVID-19 case management [by gender]Value0.001601.005000.00
    DateDecember 30, 2019June 2, 2023June 30, 2024
    Comment
  • Annual joint review of project implementationValue0.001.002.00
    DateApril 30, 2020June 2, 2023June 30, 2024
    Comment
  • Preparation of Bi-annual report on project beneficiaries’ feed-backs and resolutionsValueNOYESYES
    DateMay 31, 2020June 2, 2023June 30, 2024
    Comment
  • Percentage of designated health facilities with an improved water source on premisesValue40.000.0060.00
    DateDecember 31, 2019June 2, 2023June 30, 2024
    Comment
  • DHIS2 COVID-19 Vaccine delivery Tool Kit implemented (YES/No)ValueNONOYES
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Number of health workers who are fully vaccinated against COVID-19 [by gender]Value0.0083750.0060000.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Number of Health Facilities equipped with energy efficient storage facilities for vaccines and temperature sensitive medical suppliesValue0.000.001500.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment
  • Monthly average number of deliveries attended by skilled personnelValue47000.0043633.0050000.00
    DateDecember 31, 2020June 2, 2023June 30, 2024
    Comment